Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingersoll Rand (IR) Cash & Equivalents (2016 - 2026)

Ingersoll Rand filings provide 12 years of Cash & Equivalents readings, the most recent being $1.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 20.98% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 20.98% decrease, with the full-year FY2025 number at $1.2 billion, down 18.97% from a year prior.
  • Cash & Equivalents hit $1.3 billion in Q1 2026 for Ingersoll Rand, up from $1.2 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.0 billion in Q1 2022 to a low of $1.1 billion in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $1.3 billion (2025), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Cash & Equivalents: crashed 64.33% in 2022 and later rose 29.75% in 2024.
  • Ingersoll Rand's Cash & Equivalents stood at $1.6 billion in 2022, then decreased by 1.08% to $1.6 billion in 2023, then dropped by 3.4% to $1.5 billion in 2024, then dropped by 18.97% to $1.2 billion in 2025, then increased by 2.05% to $1.3 billion in 2026.
  • The last three reported values for Cash & Equivalents were $1.3 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025) per Business Quant data.